Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

DSpace Repository

Pimasertib Versus Dacarbazine in Patients With UnresectableNRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Author: Lebbe, Celeste; Dutriaux, Caroline; Lesimple, Thierry; Kruit, Willem; Kerger, Joseph; Thomas, Luc; Guillot, Bernard; de Braud, Filippo; Garbe, Claus; Grob, Jean-Jacques; Loquai, Carmen; Ferraresi, Virginia; Robert, Caroline; Vasey, Paul; Conry, Robert; Isaacs, Richard; Espinosa, Enrique; Schueler, Armin; Massimini, Giorgio; Dreno, Brigitte
Tübinger Autor(en):
Garbe, Claus
Published in: Cancers (2020), Bd. 12 (7), Article 1727
Verlagsangabe: Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers12071727
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)